Pharmacogenetics of the Metabolic Disturbances and Atherosclerosis Associated with Antiretroviral Therapy in HIV-Infected Patients
Sergi Veloso, Francesc Vidal(Institut de Recerca Biomèdica Catalunya Sud), Antoni Soriano‐Arandes(Vall d'Hebron Institut de Recerca), Fréderic Gómez-Bertomeu, Consuelo Viladés(Hospital Universitario Fundación Jiménez Díaz), Miguel López-Dupla, Montserrat Olona(Institut de Recerca Biomèdica Catalunya Sud), Joaquim Peraire(Instituto de Salud Carlos III), Graciano García‐Pardo(Instituto de Salud Carlos III), Joan-Josep Sirvent(Institut de Recerca Biomèdica Catalunya Sud), Xavier Escoté(Technological Center of Nutrition and Health)
Cited by 12
Related Papers
Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis
|PLoS Medicine|2018|155
Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study
|The Lancet HIV|2021|110
Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004–2013
|Journal of Infection|2016|89
Immunometabolism is a key factor for the persistent spontaneous elite control of HIV-1 infection
|EBioMedicine|2019|81
Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection
|Journal of Virology|2017|78